Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EP Vantage: Eliquis projected sales off 60% for 2014
EP Vantage: Eliquis projected sales off 60% for 2014
EP Vantage: Eliquis projected sales off 60% for 2014
Submitted by
admin
on October 18, 2013 - 11:04am
Source:
Fierce Pharma
News Tags:
Eliquis
bloodthinners
Pfizer
Bristol-Myers Squibb
Headline:
EP Vantage: Eliquis projected sales off 60% for 2014
Do Not Allow Advertisers to Use My Personal information
